Hye Y. Chung

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Long-Term Mortality in Patients with Myasthenia Gravis: A Nationwide Population-Based Cohort Study in Korea.

Long-Term Mortality in Patients with Myasthenia Gravis: A Nationwide Population-Based Cohort Study in Korea.

Journal: Neuroepidemiology

Published: November 03, 2025

Germinal centers are associated with poor prognosis in patients with thymoma-associated myasthenia gravis.

Germinal centers are associated with poor prognosis in patients with thymoma-associated myasthenia gravis.

Journal: Journal of neuroimmunology

Published: June 02, 2025

Treatment Patterns and Outcomes of Anti-MuSK Antibody-Positive Myasthenia Gravis: A Retrospective Single-Center Study.

Treatment Patterns and Outcomes of Anti-MuSK Antibody-Positive Myasthenia Gravis: A Retrospective Single-Center Study.

Journal: Journal of Korean medical science

Published: April 24, 2025

Estradiol rescues male hydroxyl radical-mediated Charcot-Marie-Tooth 2Z by Morc2a stabilization through autophagy inhibition in a murine model.

Estradiol rescues male hydroxyl radical-mediated Charcot-Marie-Tooth 2Z by Morc2a stabilization through autophagy inhibition in a murine model.

Journal: Acta neuropathologica

Published: April 15, 2025

Development and Application of a Cell-Based Assay for Detecting Anti-Agrin Antibodies Associated With Myasthenia Gravis.

Development and Application of a Cell-Based Assay for Detecting Anti-Agrin Antibodies Associated With Myasthenia Gravis.

Journal: Journal of clinical neurology (Seoul, Korea)

Published: September 16, 2024

Polyphenol-Enabled 2D Nanopatch for Enhanced Nasal Mucoadhesion and Immune Activation.

Polyphenol-Enabled 2D Nanopatch for Enhanced Nasal Mucoadhesion and Immune Activation.

Journal: Nano letters

Published: August 09, 2024

Morc2a variants cause hydroxyl radical-mediated neuropathy and are rescued by restoring GHKL ATPase.

Morc2a variants cause hydroxyl radical-mediated neuropathy and are rescued by restoring GHKL ATPase.

Journal: Brain : a journal of neurology

Published: July 31, 2023

In vivo genome editing using 244-cis LNPs and low-dose AAV achieves therapeutic threshold in hemophilia A mice.

In vivo genome editing using 244-cis LNPs and low-dose AAV achieves therapeutic threshold in hemophilia A mice.

Journal: Molecular therapy. Nucleic acids

Published: May 25, 2023

Germinal centers are associated with postthymectomy myasthenia gravis in patients with thymoma.

Germinal centers are associated with postthymectomy myasthenia gravis in patients with thymoma.

Journal: European journal of neurology

Published: February 17, 2023

Anti-titin antibodies are associated with myocarditis in patients with myasthenia gravis.

Anti-titin antibodies are associated with myocarditis in patients with myasthenia gravis.

Journal: Journal of neurology

Published: August 22, 2022

Anti-titin antibody is associated with more frequent hospitalization to manage thymoma-associated myasthenia gravis.

Anti-titin antibody is associated with more frequent hospitalization to manage thymoma-associated myasthenia gravis.

Journal: Frontiers in neurology

Published: June 27, 2022

Thymectomy and disease duration in non-thymomatous acetylcholine receptor antibody-positive myasthenia gravis: a single-centre, cross-sectional study.

Thymectomy and disease duration in non-thymomatous acetylcholine receptor antibody-positive myasthenia gravis: a single-centre, cross-sectional study.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: June 23, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026